ArticleFrontiers in pediatrics2021

Case Report: Off-Label Use of Omalizumab in a 6-Year-Old Boy With ASD Ameliorated Severe Allergic Rhinitis and Subsequently Improved Behavioral Symptoms.

Xue-Jun Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.